A2 share price frenzy – but is the US formula market worth it?

A2 share price frenzy – but is the US formula market worth it?
The American dream may not be worth it for A2. (Image: Getty)
Jenny Ruth
Some investors believe accessing the US infant formula market would be a big deal for Fonterra and the A2 Milk Company, and trading in A2’s shares last week highlighted that fact.An Australian Financial Review (AFR) journalist got a little over her skis on Tuesday and published a story saying A2 could get US Food & Drug Administration (FDA) approval “as soon as this week”.Both Fonterra and A2 have been waiting for this approval since they applied in late May after the FDA made public it was looking to facilitate infant for...

More Primary Sector

Bremworth getting back into synthetics
Primary Sector

Bremworth getting back into synthetics

Albeit in a small, but carefully curated, number of products.

Riley Kennedy 09 May 2025
Agriculture the winner in senior science advisory roles
Primary Sector

Agriculture the winner in senior science advisory roles

The Science & Technology Advisory Council is weighted towards the dairy industry.

Greg Hurrell 08 May 2025